SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-021951
Filing Date
2021-04-29
Accepted
2021-04-29 16:09:50
Documents
4
Period of Report
2021-06-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A kura-def14a_20210622.htm DEF 14A 1434399
2 GRAPHIC gmas33tiwrsi000001.jpg GRAPHIC 2068
3 GRAPHIC gmas33tiwrsi000002.jpg GRAPHIC 217992
4 GRAPHIC gmas33tiwrsi000003.jpg GRAPHIC 133423
  Complete submission text file 0001564590-21-021951.txt   1922524
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37620 | Film No.: 21870615
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences